OncoSwab Sàrl

Early detection of lung cancer can greatly improve survival rates, but due to cost-effectivity, accessibility and safety issues, screening is only performed in some countries under very specific conditions. In Europe, only 4 countries have implemented a screening program resulting in 75% of patients being detected at late stages and more than 50% of patients dying within 1 year of diagnosis. OncoSwab is a startup founded by Andrea Stephany and Dr. Pablo Lara, and we are developing a point-of-care test that can be performed in various healthcare settings. By making screening more accessible to patients, our goal is to help make early lung cancer detection the rule. The global cancer diagnostics market size is around $160 billion million globally.